B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co
Joint marketing of CytoSorb® with B. Braun’s newest OMNI® blood purification platform will offer greater access of this advanced treatment of deadly inflammation to critically ill patients. MELSUNGEN, Germany and MONMOUTH JUNCTION, N.J., March 2, 2021 /PRNewswire/ — B. Braun Avitum AG, a leading manufacturer of medical devices and pharmaceutical products and services and CytoSorbents Corporation […]
B. Braun Avitum Company Profile: Valuation, Investors, Acquisition
Digital Diabetes Management Market Size, Trends & Forecast
In this image released on Tuesday, March 2, 2021, the CytoSorb® adsorber is used in critical care for the extracorporeal removal of cytokines and inflammatory mediators from the bloodstream. B. Braun Avitum
Stock Market News 2021-03-02
Digital Diabetes Management Market Size, Trends & Forecast
Digital Diabetes Management Market Size, Trends & Forecast
World premiere: Viva Frida Kahlo – Immersive Experience
Leap by McKinsey Research Shows 50 Percent of Global Revenue Will
B. Braun and CytoSorbents Announce Global Co-Marketing Agreement
Hip Replacement Devices Market Size, Share, Trends, Scope & Forecast
B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote th - English
Stock Market News 2021-03-02
Facts & Figures - B. Braun
Memic Receives FDA Authorization for Hominis® Robot-Assisted
